| __timestamp | Alpine Immune Sciences, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 90480000 |
| Thursday, January 1, 2015 | 6844000 | 133384000 |
| Friday, January 1, 2016 | 8586000 | 179997000 |
| Sunday, January 1, 2017 | 6079000 | 220119000 |
| Monday, January 1, 2018 | 8362000 | 258528000 |
| Tuesday, January 1, 2019 | 9467000 | 198205000 |
| Wednesday, January 1, 2020 | 10899000 | 181022000 |
| Friday, January 1, 2021 | 14560000 | 198359000 |
| Saturday, January 1, 2022 | 17968000 | 208789000 |
| Sunday, January 1, 2023 | 22222000 | 211124000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology and medical devices, understanding financial trends is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and MiMedx Group, Inc. from 2014 to 2023. Over this period, MiMedx consistently outspent Alpine, with its SG&A expenses peaking at over 250% higher in 2018. However, Alpine's expenses have shown a steady upward trajectory, increasing nearly tenfold from 2014 to 2023. This growth reflects Alpine's strategic investments in scaling operations and expanding market reach. Meanwhile, MiMedx's expenses have fluctuated, indicating potential shifts in business strategy or market conditions. As of 2023, both companies are navigating a complex financial landscape, with Alpine's expenses reaching approximately 22 million, while MiMedx's stand at around 211 million. These trends offer valuable insights into each company's operational priorities and market positioning.
Comparing SG&A Expenses: Merck & Co., Inc. vs MiMedx Group, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? United Therapeutics Corporation or Alpine Immune Sciences, Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and MiMedx Group, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Apellis Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Breaking Down SG&A Expenses: PTC Therapeutics, Inc. vs MiMedx Group, Inc.